Global PET Radiopharmaceuticals Market Research Report 2023(Status and Outlook)
Report Overview
Bosson Research’s latest report provides a deep insight into the global PET Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PET Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PET Radiopharmaceuticals market in any manner.
Global PET Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market Segmentation (by Type)
F-18
Ru-82
Others
Market Segmentation (by Application)
Oncology
Cardiology
Neurology
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PET Radiopharmaceuticals Market
Overview of the regional outlook of the PET Radiopharmaceuticals Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PET Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Bosson Research’s latest report provides a deep insight into the global PET Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PET Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PET Radiopharmaceuticals market in any manner.
Global PET Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Market Segmentation (by Type)
F-18
Ru-82
Others
Market Segmentation (by Application)
Oncology
Cardiology
Neurology
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PET Radiopharmaceuticals Market
Overview of the regional outlook of the PET Radiopharmaceuticals Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PET Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PET Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 PET Radiopharmaceuticals Segment by Type
1.2.2 PET Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PET RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PET Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global PET Radiopharmaceuticals Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PET RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global PET Radiopharmaceuticals Sales by Manufacturers (2018-2023)
3.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2018-2023)
3.3 PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PET Radiopharmaceuticals Average Price by Manufacturers (2018-2023)
3.5 Manufacturers PET Radiopharmaceuticals Sales Sites, Area Served, Product Type
3.6 PET Radiopharmaceuticals Market Competitive Situation and Trends
3.6.1 PET Radiopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest PET Radiopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PET RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 PET Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PET RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PET RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PET Radiopharmaceuticals Sales Market Share by Type (2018-2023)
6.3 Global PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
6.4 Global PET Radiopharmaceuticals Price by Type (2018-2023)
7 PET RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PET Radiopharmaceuticals Market Sales by Application (2018-2023)
7.3 Global PET Radiopharmaceuticals Market Size (M USD) by Application (2018-2023)
7.4 Global PET Radiopharmaceuticals Sales Growth Rate by Application (2018-2023)
8 PET RADIOPHARMACEUTICALS MARKET SEGMENTATION BY REGION
8.1 Global PET Radiopharmaceuticals Sales by Region
8.1.1 Global PET Radiopharmaceuticals Sales by Region
8.1.2 Global PET Radiopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America PET Radiopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PET Radiopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PET Radiopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PET Radiopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PET Radiopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cardinal Health Inc. (U.S.)
9.1.1 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Basic Information
9.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Overview
9.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Market Performance
9.1.4 Cardinal Health Inc. (U.S.) Business Overview
9.1.5 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
9.1.6 Cardinal Health Inc. (U.S.) Recent Developments
9.2 Mallinckrodt plc (Ireland)
9.2.1 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Basic Information
9.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Overview
9.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Market Performance
9.2.4 Mallinckrodt plc (Ireland) Business Overview
9.2.5 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis
9.2.6 Mallinckrodt plc (Ireland) Recent Developments
9.3 GE Healthcare (U.K.)
9.3.1 GE Healthcare (U.K.) PET Radiopharmaceuticals Basic Information
9.3.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Overview
9.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Market Performance
9.3.4 GE Healthcare (U.K.) Business Overview
9.3.5 GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis
9.3.6 GE Healthcare (U.K.) Recent Developments
9.4 Lantheus Medical Imaging, Inc. (U.S.)
9.4.1 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Basic Information
9.4.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Overview
9.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Market Performance
9.4.4 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
9.4.5 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
9.4.6 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
9.5 Bayer AG (Germany)
9.5.1 Bayer AG (Germany) PET Radiopharmaceuticals Basic Information
9.5.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Overview
9.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Product Market Performance
9.5.4 Bayer AG (Germany) Business Overview
9.5.5 Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis
9.5.6 Bayer AG (Germany) Recent Developments
9.6 Bracco Imaging S.p.A (Italy)
9.6.1 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Basic Information
9.6.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Overview
9.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Market Performance
9.6.4 Bracco Imaging S.p.A (Italy) Business Overview
9.6.5 Bracco Imaging S.p.A (Italy) Recent Developments
9.7 Eczacibasi-Monrol Nuclear Products (Turkey)
9.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Basic Information
9.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Overview
9.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Market Performance
9.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
9.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
9.8 Nordion, Inc. (Canada)
9.8.1 Nordion, Inc. (Canada) PET Radiopharmaceuticals Basic Information
9.8.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Overview
9.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Market Performance
9.8.4 Nordion, Inc. (Canada) Business Overview
9.8.5 Nordion, Inc. (Canada) Recent Developments
9.9 Advanced Accelerator Applications S.A. (France)
9.9.1 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Basic Information
9.9.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Overview
9.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Market Performance
9.9.4 Advanced Accelerator Applications S.A. (France) Business Overview
9.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments
9.10 IBA Molecular Imaging (Belgium)
9.10.1 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Basic Information
9.10.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Overview
9.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Market Performance
9.10.4 IBA Molecular Imaging (Belgium) Business Overview
9.10.5 IBA Molecular Imaging (Belgium) Recent Developments
10 PET RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
10.1 Global PET Radiopharmaceuticals Market Size Forecast
10.2 Global PET Radiopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PET Radiopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific PET Radiopharmaceuticals Market Size Forecast by Region
10.2.4 South America PET Radiopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PET Radiopharmaceuticals by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global PET Radiopharmaceuticals Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of PET Radiopharmaceuticals by Type (2024-2029)
11.1.2 Global PET Radiopharmaceuticals Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of PET Radiopharmaceuticals by Type (2024-2029)
11.2 Global PET Radiopharmaceuticals Market Forecast by Application (2024-2029)
11.2.1 Global PET Radiopharmaceuticals Sales (K MT) Forecast by Application
11.2.2 Global PET Radiopharmaceuticals Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PET Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 PET Radiopharmaceuticals Segment by Type
1.2.2 PET Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PET RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PET Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global PET Radiopharmaceuticals Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PET RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Global PET Radiopharmaceuticals Sales by Manufacturers (2018-2023)
3.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2018-2023)
3.3 PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PET Radiopharmaceuticals Average Price by Manufacturers (2018-2023)
3.5 Manufacturers PET Radiopharmaceuticals Sales Sites, Area Served, Product Type
3.6 PET Radiopharmaceuticals Market Competitive Situation and Trends
3.6.1 PET Radiopharmaceuticals Market Concentration Rate
3.6.2 Global 5 and 10 Largest PET Radiopharmaceuticals Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PET RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 PET Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PET RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PET RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PET Radiopharmaceuticals Sales Market Share by Type (2018-2023)
6.3 Global PET Radiopharmaceuticals Market Size Market Share by Type (2018-2023)
6.4 Global PET Radiopharmaceuticals Price by Type (2018-2023)
7 PET RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PET Radiopharmaceuticals Market Sales by Application (2018-2023)
7.3 Global PET Radiopharmaceuticals Market Size (M USD) by Application (2018-2023)
7.4 Global PET Radiopharmaceuticals Sales Growth Rate by Application (2018-2023)
8 PET RADIOPHARMACEUTICALS MARKET SEGMENTATION BY REGION
8.1 Global PET Radiopharmaceuticals Sales by Region
8.1.1 Global PET Radiopharmaceuticals Sales by Region
8.1.2 Global PET Radiopharmaceuticals Sales Market Share by Region
8.2 North America
8.2.1 North America PET Radiopharmaceuticals Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PET Radiopharmaceuticals Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PET Radiopharmaceuticals Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PET Radiopharmaceuticals Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PET Radiopharmaceuticals Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cardinal Health Inc. (U.S.)
9.1.1 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Basic Information
9.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Overview
9.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Market Performance
9.1.4 Cardinal Health Inc. (U.S.) Business Overview
9.1.5 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
9.1.6 Cardinal Health Inc. (U.S.) Recent Developments
9.2 Mallinckrodt plc (Ireland)
9.2.1 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Basic Information
9.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Overview
9.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Market Performance
9.2.4 Mallinckrodt plc (Ireland) Business Overview
9.2.5 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis
9.2.6 Mallinckrodt plc (Ireland) Recent Developments
9.3 GE Healthcare (U.K.)
9.3.1 GE Healthcare (U.K.) PET Radiopharmaceuticals Basic Information
9.3.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Overview
9.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Market Performance
9.3.4 GE Healthcare (U.K.) Business Overview
9.3.5 GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis
9.3.6 GE Healthcare (U.K.) Recent Developments
9.4 Lantheus Medical Imaging, Inc. (U.S.)
9.4.1 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Basic Information
9.4.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Overview
9.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Market Performance
9.4.4 Lantheus Medical Imaging, Inc. (U.S.) Business Overview
9.4.5 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
9.4.6 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
9.5 Bayer AG (Germany)
9.5.1 Bayer AG (Germany) PET Radiopharmaceuticals Basic Information
9.5.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Overview
9.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Product Market Performance
9.5.4 Bayer AG (Germany) Business Overview
9.5.5 Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis
9.5.6 Bayer AG (Germany) Recent Developments
9.6 Bracco Imaging S.p.A (Italy)
9.6.1 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Basic Information
9.6.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Overview
9.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Market Performance
9.6.4 Bracco Imaging S.p.A (Italy) Business Overview
9.6.5 Bracco Imaging S.p.A (Italy) Recent Developments
9.7 Eczacibasi-Monrol Nuclear Products (Turkey)
9.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Basic Information
9.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Overview
9.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Market Performance
9.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
9.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
9.8 Nordion, Inc. (Canada)
9.8.1 Nordion, Inc. (Canada) PET Radiopharmaceuticals Basic Information
9.8.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Overview
9.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Market Performance
9.8.4 Nordion, Inc. (Canada) Business Overview
9.8.5 Nordion, Inc. (Canada) Recent Developments
9.9 Advanced Accelerator Applications S.A. (France)
9.9.1 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Basic Information
9.9.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Overview
9.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Market Performance
9.9.4 Advanced Accelerator Applications S.A. (France) Business Overview
9.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments
9.10 IBA Molecular Imaging (Belgium)
9.10.1 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Basic Information
9.10.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Overview
9.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Market Performance
9.10.4 IBA Molecular Imaging (Belgium) Business Overview
9.10.5 IBA Molecular Imaging (Belgium) Recent Developments
10 PET RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
10.1 Global PET Radiopharmaceuticals Market Size Forecast
10.2 Global PET Radiopharmaceuticals Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PET Radiopharmaceuticals Market Size Forecast by Country
10.2.3 Asia Pacific PET Radiopharmaceuticals Market Size Forecast by Region
10.2.4 South America PET Radiopharmaceuticals Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PET Radiopharmaceuticals by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global PET Radiopharmaceuticals Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of PET Radiopharmaceuticals by Type (2024-2029)
11.1.2 Global PET Radiopharmaceuticals Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of PET Radiopharmaceuticals by Type (2024-2029)
11.2 Global PET Radiopharmaceuticals Market Forecast by Application (2024-2029)
11.2.1 Global PET Radiopharmaceuticals Sales (K MT) Forecast by Application
11.2.2 Global PET Radiopharmaceuticals Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PET Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global PET Radiopharmaceuticals Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
Table 7. Global PET Radiopharmaceuticals Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2022)
Table 10. Global Market PET Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers PET Radiopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers PET Radiopharmaceuticals Product Type
Table 13. Global PET Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PET Radiopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PET Radiopharmaceuticals Market Challenges
Table 22. Market Restraints
Table 23. Global PET Radiopharmaceuticals Sales by Type (K MT)
Table 24. Global PET Radiopharmaceuticals Market Size by Type (M USD)
Table 25. Global PET Radiopharmaceuticals Sales (K MT) by Type (2018-2023)
Table 26. Global PET Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Table 27. Global PET Radiopharmaceuticals Market Size (M USD) by Type (2018-2023)
Table 28. Global PET Radiopharmaceuticals Market Size Share by Type (2018-2023)
Table 29. Global PET Radiopharmaceuticals Price (USD/MT) by Type (2018-2023)
Table 30. Global PET Radiopharmaceuticals Sales (K MT) by Application
Table 31. Global PET Radiopharmaceuticals Market Size by Application
Table 32. Global PET Radiopharmaceuticals Sales by Application (2018-2023) & (K MT)
Table 33. Global PET Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Table 34. Global PET Radiopharmaceuticals Sales by Application (2018-2023) & (M USD)
Table 35. Global PET Radiopharmaceuticals Market Share by Application (2018-2023)
Table 36. Global PET Radiopharmaceuticals Sales Growth Rate by Application (2018-2023)
Table 37. Global PET Radiopharmaceuticals Sales by Region (2018-2023) & (K MT)
Table 38. Global PET Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Table 39. North America PET Radiopharmaceuticals Sales by Country (2018-2023) & (K MT)
Table 40. Europe PET Radiopharmaceuticals Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific PET Radiopharmaceuticals Sales by Region (2018-2023) & (K MT)
Table 42. South America PET Radiopharmaceuticals Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa PET Radiopharmaceuticals Sales by Region (2018-2023) & (K MT)
Table 44. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Basic Information
Table 45. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Overview
Table 46. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Cardinal Health Inc. (U.S.) Business Overview
Table 48. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
Table 49. Cardinal Health Inc. (U.S.) Recent Developments
Table 50. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Basic Information
Table 51. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Overview
Table 52. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Mallinckrodt plc (Ireland) Business Overview
Table 54. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis
Table 55. Mallinckrodt plc (Ireland) Recent Developments
Table 56. GE Healthcare (U.K.) PET Radiopharmaceuticals Basic Information
Table 57. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Overview
Table 58. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. GE Healthcare (U.K.) Business Overview
Table 60. GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis
Table 61. GE Healthcare (U.K.) Recent Developments
Table 62. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Basic Information
Table 63. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Overview
Table 64. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Lantheus Medical Imaging, Inc. (U.S.) Business Overview
Table 66. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
Table 67. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
Table 68. Bayer AG (Germany) PET Radiopharmaceuticals Basic Information
Table 69. Bayer AG (Germany) PET Radiopharmaceuticals Product Overview
Table 70. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Bayer AG (Germany) Business Overview
Table 72. Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis
Table 73. Bayer AG (Germany) Recent Developments
Table 74. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Basic Information
Table 75. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Overview
Table 76. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Bracco Imaging S.p.A (Italy) Business Overview
Table 78. Bracco Imaging S.p.A (Italy) Recent Developments
Table 79. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Basic Information
Table 80. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Overview
Table 81. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
Table 83. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
Table 84. Nordion, Inc. (Canada) PET Radiopharmaceuticals Basic Information
Table 85. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Overview
Table 86. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Nordion, Inc. (Canada) Business Overview
Table 88. Nordion, Inc. (Canada) Recent Developments
Table 89. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Basic Information
Table 90. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Overview
Table 91. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Advanced Accelerator Applications S.A. (France) Business Overview
Table 93. Advanced Accelerator Applications S.A. (France) Recent Developments
Table 94. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Basic Information
Table 95. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Overview
Table 96. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. IBA Molecular Imaging (Belgium) Business Overview
Table 98. IBA Molecular Imaging (Belgium) Recent Developments
Table 99. Global PET Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K MT)
Table 100. Global PET Radiopharmaceuticals Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America PET Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K MT)
Table 102. North America PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe PET Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K MT)
Table 104. Europe PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific PET Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K MT)
Table 106. Asia Pacific PET Radiopharmaceuticals Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America PET Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K MT)
Table 108. South America PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa PET Radiopharmaceuticals Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 111. Global PET Radiopharmaceuticals Sales Forecast by Type (2024-2029) & (K MT)
Table 112. Global PET Radiopharmaceuticals Market Size Forecast by Type (2024-2029) & (M USD)
Table 113. Global PET Radiopharmaceuticals Price Forecast by Type (2024-2029) & (USD/MT)
Table 114. Global PET Radiopharmaceuticals Sales (K MT) Forecast by Application (2024-2029)
Table 115. Global PET Radiopharmaceuticals Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PET Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 5. Global PET Radiopharmaceuticals Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
Table 7. Global PET Radiopharmaceuticals Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2022)
Table 10. Global Market PET Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers PET Radiopharmaceuticals Sales Sites and Area Served
Table 12. Manufacturers PET Radiopharmaceuticals Product Type
Table 13. Global PET Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PET Radiopharmaceuticals
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PET Radiopharmaceuticals Market Challenges
Table 22. Market Restraints
Table 23. Global PET Radiopharmaceuticals Sales by Type (K MT)
Table 24. Global PET Radiopharmaceuticals Market Size by Type (M USD)
Table 25. Global PET Radiopharmaceuticals Sales (K MT) by Type (2018-2023)
Table 26. Global PET Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Table 27. Global PET Radiopharmaceuticals Market Size (M USD) by Type (2018-2023)
Table 28. Global PET Radiopharmaceuticals Market Size Share by Type (2018-2023)
Table 29. Global PET Radiopharmaceuticals Price (USD/MT) by Type (2018-2023)
Table 30. Global PET Radiopharmaceuticals Sales (K MT) by Application
Table 31. Global PET Radiopharmaceuticals Market Size by Application
Table 32. Global PET Radiopharmaceuticals Sales by Application (2018-2023) & (K MT)
Table 33. Global PET Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Table 34. Global PET Radiopharmaceuticals Sales by Application (2018-2023) & (M USD)
Table 35. Global PET Radiopharmaceuticals Market Share by Application (2018-2023)
Table 36. Global PET Radiopharmaceuticals Sales Growth Rate by Application (2018-2023)
Table 37. Global PET Radiopharmaceuticals Sales by Region (2018-2023) & (K MT)
Table 38. Global PET Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Table 39. North America PET Radiopharmaceuticals Sales by Country (2018-2023) & (K MT)
Table 40. Europe PET Radiopharmaceuticals Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific PET Radiopharmaceuticals Sales by Region (2018-2023) & (K MT)
Table 42. South America PET Radiopharmaceuticals Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa PET Radiopharmaceuticals Sales by Region (2018-2023) & (K MT)
Table 44. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Basic Information
Table 45. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Overview
Table 46. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Cardinal Health Inc. (U.S.) Business Overview
Table 48. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
Table 49. Cardinal Health Inc. (U.S.) Recent Developments
Table 50. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Basic Information
Table 51. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Overview
Table 52. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Mallinckrodt plc (Ireland) Business Overview
Table 54. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals SWOT Analysis
Table 55. Mallinckrodt plc (Ireland) Recent Developments
Table 56. GE Healthcare (U.K.) PET Radiopharmaceuticals Basic Information
Table 57. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Overview
Table 58. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. GE Healthcare (U.K.) Business Overview
Table 60. GE Healthcare (U.K.) PET Radiopharmaceuticals SWOT Analysis
Table 61. GE Healthcare (U.K.) Recent Developments
Table 62. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Basic Information
Table 63. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Overview
Table 64. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Lantheus Medical Imaging, Inc. (U.S.) Business Overview
Table 66. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals SWOT Analysis
Table 67. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments
Table 68. Bayer AG (Germany) PET Radiopharmaceuticals Basic Information
Table 69. Bayer AG (Germany) PET Radiopharmaceuticals Product Overview
Table 70. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Bayer AG (Germany) Business Overview
Table 72. Bayer AG (Germany) PET Radiopharmaceuticals SWOT Analysis
Table 73. Bayer AG (Germany) Recent Developments
Table 74. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Basic Information
Table 75. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Overview
Table 76. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Bracco Imaging S.p.A (Italy) Business Overview
Table 78. Bracco Imaging S.p.A (Italy) Recent Developments
Table 79. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Basic Information
Table 80. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Overview
Table 81. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Eczacibasi-Monrol Nuclear Products (Turkey) Business Overview
Table 83. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments
Table 84. Nordion, Inc. (Canada) PET Radiopharmaceuticals Basic Information
Table 85. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Overview
Table 86. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Nordion, Inc. (Canada) Business Overview
Table 88. Nordion, Inc. (Canada) Recent Developments
Table 89. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Basic Information
Table 90. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Overview
Table 91. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Advanced Accelerator Applications S.A. (France) Business Overview
Table 93. Advanced Accelerator Applications S.A. (France) Recent Developments
Table 94. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Basic Information
Table 95. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Overview
Table 96. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. IBA Molecular Imaging (Belgium) Business Overview
Table 98. IBA Molecular Imaging (Belgium) Recent Developments
Table 99. Global PET Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K MT)
Table 100. Global PET Radiopharmaceuticals Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America PET Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K MT)
Table 102. North America PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe PET Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K MT)
Table 104. Europe PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific PET Radiopharmaceuticals Sales Forecast by Region (2024-2029) & (K MT)
Table 106. Asia Pacific PET Radiopharmaceuticals Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America PET Radiopharmaceuticals Sales Forecast by Country (2024-2029) & (K MT)
Table 108. South America PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa PET Radiopharmaceuticals Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa PET Radiopharmaceuticals Market Size Forecast by Country (2024-2029) & (M USD)
Table 111. Global PET Radiopharmaceuticals Sales Forecast by Type (2024-2029) & (K MT)
Table 112. Global PET Radiopharmaceuticals Market Size Forecast by Type (2024-2029) & (M USD)
Table 113. Global PET Radiopharmaceuticals Price Forecast by Type (2024-2029) & (USD/MT)
Table 114. Global PET Radiopharmaceuticals Sales (K MT) Forecast by Application (2024-2029)
Table 115. Global PET Radiopharmaceuticals Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PET Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PET Radiopharmaceuticals Market Size (M USD), 2018-2029
Figure 5. Global PET Radiopharmaceuticals Market Size (M USD) (2018-2029)
Figure 6. Global PET Radiopharmaceuticals Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PET Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. PET Radiopharmaceuticals Sales Share by Manufacturers in 2022
Figure 12. Global PET Radiopharmaceuticals Revenue Share by Manufacturers in 2022
Figure 13. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market PET Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by PET Radiopharmaceuticals Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PET Radiopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of PET Radiopharmaceuticals by Type (2018-2023)
Figure 19. Sales Market Share of PET Radiopharmaceuticals by Type in 2022
Figure 20. Market Size Share of PET Radiopharmaceuticals by Type (2018-2023)
Figure 21. Market Size Market Share of PET Radiopharmaceuticals by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PET Radiopharmaceuticals Market Share by Application
Figure 24. Global PET Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 25. Global PET Radiopharmaceuticals Sales Market Share by Application in 2022
Figure 26. Global PET Radiopharmaceuticals Market Share by Application (2018-2023)
Figure 27. Global PET Radiopharmaceuticals Market Share by Application in 2022
Figure 28. Global PET Radiopharmaceuticals Sales Growth Rate by Application (2018-2023)
Figure 29. Global PET Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Figure 30. North America PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America PET Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 32. U.S. PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada PET Radiopharmaceuticals Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico PET Radiopharmaceuticals Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 37. Germany PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific PET Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 43. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region in 2022
Figure 44. China PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America PET Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 50. South America PET Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 51. Brazil PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa PET Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Region in 2022
Figure 56. Saudi Arabia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global PET Radiopharmaceuticals Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global PET Radiopharmaceuticals Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global PET Radiopharmaceuticals Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global PET Radiopharmaceuticals Market Share Forecast by Type (2024-2029)
Figure 65. Global PET Radiopharmaceuticals Sales Forecast by Application (2024-2029)
Figure 66. Global PET Radiopharmaceuticals Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of PET Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PET Radiopharmaceuticals Market Size (M USD), 2018-2029
Figure 5. Global PET Radiopharmaceuticals Market Size (M USD) (2018-2029)
Figure 6. Global PET Radiopharmaceuticals Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PET Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. PET Radiopharmaceuticals Sales Share by Manufacturers in 2022
Figure 12. Global PET Radiopharmaceuticals Revenue Share by Manufacturers in 2022
Figure 13. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market PET Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by PET Radiopharmaceuticals Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PET Radiopharmaceuticals Market Share by Type
Figure 18. Sales Market Share of PET Radiopharmaceuticals by Type (2018-2023)
Figure 19. Sales Market Share of PET Radiopharmaceuticals by Type in 2022
Figure 20. Market Size Share of PET Radiopharmaceuticals by Type (2018-2023)
Figure 21. Market Size Market Share of PET Radiopharmaceuticals by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PET Radiopharmaceuticals Market Share by Application
Figure 24. Global PET Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure 25. Global PET Radiopharmaceuticals Sales Market Share by Application in 2022
Figure 26. Global PET Radiopharmaceuticals Market Share by Application (2018-2023)
Figure 27. Global PET Radiopharmaceuticals Market Share by Application in 2022
Figure 28. Global PET Radiopharmaceuticals Sales Growth Rate by Application (2018-2023)
Figure 29. Global PET Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Figure 30. North America PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America PET Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 32. U.S. PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada PET Radiopharmaceuticals Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico PET Radiopharmaceuticals Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 37. Germany PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific PET Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 43. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region in 2022
Figure 44. China PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America PET Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 50. South America PET Radiopharmaceuticals Sales Market Share by Country in 2022
Figure 51. Brazil PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa PET Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Region in 2022
Figure 56. Saudi Arabia PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa PET Radiopharmaceuticals Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global PET Radiopharmaceuticals Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global PET Radiopharmaceuticals Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global PET Radiopharmaceuticals Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global PET Radiopharmaceuticals Market Share Forecast by Type (2024-2029)
Figure 65. Global PET Radiopharmaceuticals Sales Forecast by Application (2024-2029)
Figure 66. Global PET Radiopharmaceuticals Market Share Forecast by Application (2024-2029)
